Abstract
AbstractEthyl 2‐amino‐4,5‐diphenylfuran‐3‐carboxylate (2), a reactive synthon, was successfully used to synthesize a novel series of furan and furo[2,3–d]pyrimidinone analogues by interactions with the proper chemical reagents. With the aid of precise spectroscopic data (FT‐IR, Mass, 1H‐NMR, and 13C‐NMR spectra), the structures of products were clearly established. The cytotoxic results by MTT assay showed that furo[2,3–d]pyrimidinone analogues 4 (IC50=6.1±0.8 & 10.2±2.5 μM), 6 (IC50=9.2±2.1 & 17.8±0.5 μM), 11 (IC50=7.1±0.5 & 9.2±1.8 μM), 12 (IC50=5.4±2.3 & 9.8±1.7 μM), 15 (IC50=5.2±2.0 & 8.8±2.0 μM), 18 (IC50=4.2±2.4 & 10.7±1.8 μM), and 21 (IC50=12.8±1.9 & 18.8±0.9 μM) had strong in vitro cytotoxic activities to inhibit the growth of colorectal carcinoma (HCT‐116), and prostate cancer (PC3) cell lines, respectively. However, their effects on normal lung fibroblast (WI‐38) were weak in comparison to 5‐fluorouracil as a positive control. On the other hand, the biological evaluations supported the presence of strong antioxidant activity for the furo[2,3–d]pyrimidinone analogues 4, 6, 15, 17, and 21 (% inhibition=89.10, 84.16, 82.09, 88.11, and 80.23 %, respectively) when compared to ascorbic acid (88.42 %). It has been proven that the most powerful cytotoxic and antioxidant compounds have a superior protective influence on DNA against bleomycin‐induced damage.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.